Industry reports
Editor highlights

Hepatitis B Vaccines Pipeline Assessment and Market Forecasts to 2018

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 67 pages

Engerix-B (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Industries: Drug and Medication | Countries: Canada, Germany, Spain, Italy, France, World, Europe, United States, United Kingdom, Japan

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • by Global Data
  • January 2014
  • 191 pages

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - 5EU Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two ...

Industries: Drug and Medication | Countries: Spain, Italy, France, Germany, United Kingdom, Europe, World

Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 64 pages

Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Industries: Drug and Medication | Countries: World, United Kingdom, Canada, Spain, Italy, France, Germany, Japan

Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 64 pages

Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Industries: Drug and Medication | Countries: Canada, Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe

Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 91 pages

Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Industries: Drug and Medication | Countries: Canada, Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe

Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 66 pages

Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Industries: Drug and Medication | Countries: Canada, Spain, Italy, France, Germany, World, United States, United Kingdom, Europe, Japan

Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 68 pages

Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion ...

Industries: Drug and Medication | Countries: Canada, Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe

Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 67 pages

Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people ...

Industries: Drug and Medication | Countries: Canada, Spain, Italy, France, Germany, World, United States, United Kingdom, Europe, Japan

Basic Pharmaceutical Product Manufacturing Market in the UK

Basic Pharmaceutical Product Manufacturing Market in the UK

  • $ 910
  • Industry report
  • by Ibisworld
  • January 2014
  • 32 pages

Picture of health: The market shows its dynamic nature in the face of dramatic change Basic Pharmaceutical Product Manufacturing in the UK The Basic Pharmaceutical Product Manufacturing market comprises industry players that manufacture medicinal active substances that are used for their pharmacological ...

Industries: Drug and Medication | Countries: United Kingdom

United Kingdom Pharmaceuticals and Healthcare Report Q1 2014

United Kingdom Pharmaceuticals and Healthcare Report Q1 2014

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2014
  • 119 pages

Includes 3 FREE quarterly updates BMI View: The UK government's implementation of an almost 4% price cut on medicines in 2014, under a five-year agreement to slow inflation in the GBP11bn (US$15bn) annual National Health Service (NHS) medicines budget, will work against the country's business environment. ...

Industries: Drug and Medication | Countries: United Kingdom

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.